Newron Pharmaceuticals S.p.A., IT0004147952

Newron Pharmaceuticals S.p.A.: Prisca Anand, buy

Published on 08/12/2026 at 16:41 | dgap.de

Newron Pharmaceuticals S.p.A. / IT0004147952


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

12.08.2026 / 16:39 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Prisca
Last name(s): Anand

2. Reason for the notification

a) Position / status
Person closely associated with:
Title:
First name: Ravi
Last name(s): Anand
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Newron Pharmaceuticals S.p.A.

b) LEI
8156002F8C11F80A9740 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: IT0004147952

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
12.00 CHF 6,984.00 CHF

d) Aggregated information
Price Aggregated volume
12.0000 CHF 6,984.0000 CHF

e) Date of the transaction
11/08/2026; UTC+2

f) Place of the transaction
Name: SIX Swiss Exchange
MIC: XSWX


12.08.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Language: English
Company: Newron Pharmaceuticals S.p.A.
via Antonio Meucci 3
20091 Bresso
Italy
Internet: www.newron.com
LEI Code: 8156002F8C11F80A9740

 
End of News EQS News Service
106534  12.08.2026 CET/CEST
en | IT0004147952 | NEWRON PHARMACEUTICALS S.P.A. | boerse | 69941051 |